TCT-28 Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)

David Hildick-Smith,Philip Maccarthy,Michael Mullen,Lindsay Morrison,Christopher Duke,Mark Spence

Journal of the American College of Cardiology（2016）

Cited 0|Views10

No score

Abstract

Safety and efficacy data on patent foramen ovale (PFO) closure with the Occlutech Figulla Flex II device are lacking. We undertook a fully monitored prospective Registry on PFO closure using this device. 100 patients undergoing PFO closure were prospectively enrolled into the OPPOSE Registry at 6

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined